Clinical Trial Update: Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose [Phase 4]

View source ↗

Summary

Phase 4 trial comparing transition from glargine to degludec insulin with or without a bridging glargine dose in people with Type 1 diabetes; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• insulin degludec (insulin degludec)

Snippet

Sponsor: University of Washington | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2024-02-28